Senti Biosciences Holdings annual depreciation and amortization
2021
2022
2023
2024
2025
Senti Biosciences Holdings Depreciation & Amortization Growth & History (SNTI)
Senti Biosciences Holdings's depreciation and amortization was $3.6M for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.6M | −$201,000 | −5.24% |
| 2024 | 2024-12-31 | $3.8M | $277,000 | +7.78% |
| 2023 | 2023-12-31 | $3.6M | $2.2M | +154.36% |
| 2022 | 2022-12-31 | $1.4M | $631,000 | +82.05% |
| 2021 | 2021-12-31 | $769,000 | — | — |
Senti Biosciences Holdings quarterly depreciation and amortization
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $667,000 | −$247,000 | −27.02% |
| Q1 2026 | 2026-03-31 | $688,000 | −$238,000 | −25.70% |
| Q4 2025 | 2025-12-31 | $893,000 | — | — |
| Q3 2025 | 2025-09-30 | $904,000 | −$42,000 | −4.44% |
| Q2 2025 | 2025-06-30 | $914,000 | −$57,000 | −5.87% |
| Q1 2025 | 2025-03-31 | $926,000 | −$58,000 | −5.89% |
| Q3 2024 | 2024-09-30 | $946,000 | −$402,000 | −29.82% |
| Q2 2024 | 2024-06-30 | $971,000 | $171,000 | +21.38% |
| Q1 2024 | 2024-03-31 | $984,000 | $517,000 | +110.71% |
| Q3 2023 | 2023-09-30 | $1.3M | $948,000 | +237.00% |
| Q2 2023 | 2023-06-30 | $800,000 | $500,000 | +166.67% |
| Q1 2023 | 2023-03-31 | $467,000 | $227,000 | +94.58% |
| Q3 2022 | 2022-09-30 | $400,000 | $200,000 | +100.00% |
| Q2 2022 | 2022-06-30 | $300,000 | $100,000 | +50.00% |
| Q1 2022 | 2022-03-31 | $240,000 | — | — |
| Q3 2021 | 2021-09-30 | $200,000 | — | — |
| Q2 2021 | 2021-06-30 | $200,000 | — | — |
Senti Biosciences Holdings depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's depreciation and amortization increased from $769,000 to $3.6M, a change of $2.9M. The latest reported quarter, Q2 2026, shows $667,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗